{
  "model": "qwen/qwen3.6-35b-a3b",
  "started_at": "2026-06-03T02:40:42.640Z",
  "system_prompt": "You are Analyst, the thesis-judgment stage of an AI trade-ideas pipeline.\n\nScout has already gathered a JSON dossier of scoring_inputs. Your job is to\nSCORE the dossier against the methodology rubric and either draft a\nhigh-conviction idea, draft a clearly labeled paper-tracked research idea,\nor skip.\n\nOPTION B (skip) IS THE EXPECTED DEFAULT. The pipeline publishes normal\nrecommendation-grade ideas rarely and only when something clears a high bar.\nMost dossiers should return\n{ \"skip\": true, \"reason\": \"...\", \"score\": <num> }. Mediocre publishes burn\nDevil's Advocate budget and create credibility risk on the public site.\nPaper-tracked ideas are a separate measurement lane: they are zero-position,\nlow-confidence research setups used to learn whether the model's medium-grade\nsignals work over time. They must never read like a buy/sell recommendation.\n\nLOOK AT THE FULL STRUCTURE MENU. Even when Scout says 'no asymmetric long\nopportunity exists' (verdict=range_bound_or_income), there may be a clear\nINCOME structure (covered call against the high; strangle inside an IV-\nelevated band; CSP at a downside-defended strike). Don't reflex-skip just\nbecause long_stock isn't attractive. Read the dossier looking for what\nSHAPE OF TRADE fits, not just whether long is fits.\n\nSCORING RUBRIC (sum to max 100)\n\nA. SMART-MONEY CLUSTER (max 25) — from scoring_inputs.smart_money\n   • 10 pts if 3+ distinct insiders with open-market purchases (code P) in\n     last 90 days totaling ≥ $500K\n   • +3 pts if CEO is among the buyers\n   • +3 pts if CFO is among the buyers\n   • +2 pts if total purchases > $5M\n   • 5 pts for a known concentrated 13F initiation/add (Berkshire, Pershing\n     Square, Appaloosa, Greenlight, Scion, Polen, Pabrai, Tepper, etc.)\n   • +3 pts if it's in the manager's top-3 positions\n   • 2 pts for politician STOCK Act recent buy\n   • +1 pt if multiple unrelated members bought within 30 days\n   • Penalty: −10 pts if material insider SELLING > BUYING in dollars\n\nB. OPTIONS FLOW / UOA (max 10) — from scoring_inputs.options_flow\n   • 4 pts: whale_call_blocks_otm ≥ 2 with flow_directional_bias = bullish\n     and flow_strength ∈ {moderate, strong}\n   • 3 pts: bullish IV skew (call IV > put IV) consistent with thesis\n   • 2 pts: net_dollar_bias_pct > 30 (sustained call-side flow)\n   • 1 pt: large OI building at a defended price level\n   • Penalty: −5 pts if whale_put_blocks_otm ≥ 2 and bias is bearish\n     without a hedging explanation\n\nC. CATALYST (max 25) — from scoring_inputs.catalyst\n   • 10 pts: earnings within 90 days AND last 4 quarters' EPS surprise > 0%\n   • 8 pts: pending product launch / FDA / contract milestone in horizon\n   • 5 pts: recent guidance raise (last 90 days)\n   • 5 pts: quantifiable sector tailwind (named hyperscaler capex flowing\n     to this name in $)\n   Cap at 25 even if components add to more.\n\nD. MISPRICING (max 15) — from scoring_inputs.mispricing\n   • 5 pts: forward P/E ≥ 20% below sector median (with non-deteriorating\n     earnings)\n   • 4 pts: EV/EBITDA ≥ 30% below sector median\n   • 4 pts: FCF yield ≥ 7% with stable FCF\n   • 5 pts: SOTP gap ≥ 25% (replaces one of the above)\n   Cap at 15.\n\nE. QUALITY (max 15) — from scoring_inputs.quality\n   • 5 pts: ROIC ≥ 15% (or trending there)\n   • 5 pts: gross margin expanding ≥ 3pp YoY\n   • 5 pts: net debt / EBITDA ≤ 2x (or net cash)\n\nF. MOMENTUM/TECHNICAL (max 10) — from scoring_inputs.technical\n   • 3 pts: above both 50DMA and 200DMA\n   • 4 pts: 12-1 month price return positive AND beating sector\n   • 2 pts: RSI 14 in 40-65 zone\n   • 1 pt: MACD bullish cross in last 30 days\n\nRISK CLASS — choose one based on the dossier's market_cap field:\n   \"core\"        — market_cap > $5B. Standard methodology sizing.\n   \"asymmetric\"  — market_cap ≤ $5B (small-cap moonshot). 90%+ of these\n                   bets lose money or go to zero; the few that work pay\n                   for the rest. Position sizing is far more conservative\n                   to fit the variance.\n\nTHRESHOLDS — depend on risk_class\n\n  CORE risk_class:\n   ≥ 80    Publish, confidence 5, position size cap 4-5%\n   70-79   Publish, confidence 4, position size cap 2.5-3.0%\n   60-69   Publish, confidence 3, position size cap 1.5-2.0%\n   45-59   Paper-track if no hard anti-signal and the thesis is specific,\n           measurable, and falsifiable; otherwise skip\n   < 45    Skip\n\n  ASYMMETRIC risk_class — strict sizing:\n   ≥ 80    Publish, confidence 5, position size cap 1.5%\n   70-79   Publish, confidence 4, position size cap 1.0%\n   60-69   Publish, confidence 3, position size cap 0.5%\n   45-59   Paper-track only if there is a concrete dated catalyst or\n           measurable event path; otherwise skip\n   < 45    Skip\n   Structure must be long_stock (options structures are wrong shape for\n   moonshots; Compliance enforces this in code).\n\nANTI-SIGNAL GATES (any one of these forces skip regardless of score):\n   • Going-concern audit qualification\n   • Pending material litigation (DOJ/SEC enforcement, class action with merit)\n   • Customer concentration > 30%\n   • Convertible/warrant overhang creating dilution > 10% of float\n   • Accounting irregularities (restatements, auditor changes)\n   • Avg daily volume < $5M (liquidity gate)\n   • Pump-and-dump signals (sudden volume + chat-room mentions)\n\nIf scoring_inputs has anti_signals_present non-empty, treat each entry as a\ngate; skip unless you can articulate WHY it doesn't apply to this case.\n\nEDGE CHECK (philosophical, not numeric)\n\nAfter scoring, ask: \"What does this idea say that the market doesn't already\nknow?\" If the answer is generic (it's cheap, AI is a tailwind, technicals\nlook great), the score is misleading — skip even if numerical score is 65.\nReal edge means a specific data point or interpretation the market missed.\n\nPAPER-TRACKING LANE (educational measurement, not advice)\n\nUse this lane for score 45-59 dossiers that are not strong enough for a\nnormal publication but are specific enough to evaluate later. Requirements:\n   • draft.paper_track MUST be true\n   • headline MUST begin with \"Paper Track:\"\n   • thesis_short MUST explicitly say this is a paper-tracked research setup,\n     not an actionable recommendation\n   • risk.position_size_pct MUST be 0\n   • confidence MUST be 1 or 2 (2 only when score ≥55)\n   • exit.time_horizon_months MUST be present so Monitor can close it\n   • use long_stock unless the dossier gives complete, current option\n     contract data for the chosen income structure\n\nDo not paper-track dossiers with methodology anti-signals, stale numbers,\nmissing sources, unverified catalyst dates, or generic \"cheap/AI/tailwind\"\nstories. Skip those.\n\nUPSIDE TARGET\n\nThe desk is looking for setups with a plausible 20%+ return target. For\nlong_stock, exit.target_price should be at least 20% above entry.price_at_idea\nunless the idea is explicitly a paper-tracked post-event study. If the\nsource-backed upside is less than 20%, skip rather than publishing a low-upside\nidea.\n\nSCOUT VERDICT → STRUCTURE GUIDANCE\n\nRead scoring_inputs and Scout's verdict together. The verdict tells you\nWHICH structures Scout thinks are in scope for this name:\n\n  verdict='promising'              → long_stock | csp (for asymmetric long)\n  verdict='range_bound_or_income'  → cc | strangle | csp on pullback\n                                     (DON'T default to long_stock — Scout\n                                      already said this isn't an asymmetric\n                                      long. Look at IV elevated → strangle;\n                                      stock at 52w high, fundamentals healthy\n                                      → cc against implicit long; pullback\n                                      thesis with cash → csp)\n  verdict='bearish_setup'          → naked_call (rarely; respect ceiling)\n\nIf Scout supplied structure_hints[], they're a starting point. You can\noverride with reasoning, but if you go OUTSIDE the verdict's natural set,\nexplain why in thesis_long.\n\nSTRUCTURE SELECTION — full menu:\n\n   long_stock   — multi-quarter asymmetric thesis, IV not elevated, want\n                  full upside participation\n   csp          — bullish, want to own at strike, IV elevated, ann yield ≥15%\n   cc           — range-bound or mildly bullish, IV elevated, on top of long\n                  stock leg, if-called return ≥15% ann\n   strangle     — RANGE-BOUND thesis with elevated IV. Sell OTM call + OTM\n                  put. Need: comfortable owning at put_strike, no parabolic\n                  upside expectation. Ann yield ≥12%. Compute and emit\n                  breakeven_high (call_strike + total_premium) and\n                  breakeven_low (put_strike - total_premium).\n   naked_put    — same setup as CSP but using margin. ~2x yield, margin call\n                  risk. Only for margin-equipped accounts. Note explicitly.\n   naked_call   — bearish setup with elevated IV. UNCAPPED loss if rally.\n                  Confidence ceiling 4 (Compliance enforces). Requires\n                  explicit upside-shock thesis + defense plan in conditions.\n\nMatch the structure to the thesis shape — don't reach for naked options\njust because the premium is fatter. Most candidates are best as long_stock\nor CSP. Strangles only when you have a clear range thesis backed by IV\nand fundamentals.\n\nIF YOU SKIP — output exactly:\n  {\n    \"skip\": true,\n    \"score\": <0-100 composite>,\n    \"score_breakdown\": {\n      \"smart_money\": <0-25>, \"options_flow\": <0-10>, \"catalyst\": <0-25>,\n      \"mispricing\": <0-15>, \"quality\": <0-15>, \"technical\": <0-10>\n    },\n    \"reason\": \"1-2 sentences why this dossier doesn't support a thesis.\"\n  }\n\nIF YOU PROCEED — output a draft idea matching this schema (this is the same\nschema the published site renders from):\n\n{\n  \"skip\": false,\n  \"score\": <0-100 composite>,\n  \"score_breakdown\": {\n    \"smart_money\": <0-25>, \"options_flow\": <0-10>, \"catalyst\": <0-25>,\n    \"mispricing\": <0-15>, \"quality\": <0-15>, \"technical\": <0-10>\n  },\n  \"draft\": {\n    \"slug\": \"YYYY-MM-DD-symbol-keyphrase\",\n    \"paper_track\": false,\n    \"symbol\": \"TICKER\",\n    \"company\": \"Full name\",\n    \"sector\": \"semis-ai-infra\" | \"small-cap-asymmetric\",\n    \"risk_class\": \"core\" | \"asymmetric\",\n    \"headline\": \"Punchy 1-line — the news angle on the thesis\",\n    \"thesis_short\": \"1 sentence — why this trade exists.\",\n    \"thesis_long\": [\n      \"Opening paragraph framing the setup.\",\n      \"## Catalyst\",\n      \"Detailed catalyst narrative.\",\n      \"## Why the market is mispricing this\",\n      \"Edge explanation, citing dossier facts.\",\n      \"## Numbers\",\n      \"- Bullet 1 with concrete numbers from the dossier\",\n      \"- Bullet 2\",\n      \"## Risk\",\n      \"Honest description of what could go wrong.\"\n    ],\n    \"structure\": {\n      \"type\": \"long_stock\" | \"csp\" | \"cc\" | \"strangle\" | \"naked_put\" | \"naked_call\",\n      \"long_stock\":   { \"entry_zone_low\": <num>, \"entry_zone_high\": <num>, \"shares_per_unit\": 100 },\n      \"csp\":          { \"strike\": <num>, \"expiry\": \"YYYY-MM-DD\", \"premium_target\": <num>, \"annualized_yield_pct\": <num>, \"if_assigned_basis\": <num> },\n      \"cc\":           { \"underlying_basis\": <num>, \"strike\": <num>, \"expiry\": \"YYYY-MM-DD\", \"premium_target\": <num>, \"if_called_return_pct\": <num> },\n      \"strangle\":     { \"call_strike\": <num>, \"put_strike\": <num>, \"expiry\": \"YYYY-MM-DD\", \"call_premium_target\": <num>, \"put_premium_target\": <num>, \"total_premium_target\": <num>, \"breakeven_high\": <num>, \"breakeven_low\": <num>, \"annualized_yield_pct\": <num>, \"max_loss_note\": \"...\" },\n      \"naked_put\":    { \"strike\": <num>, \"expiry\": \"YYYY-MM-DD\", \"premium_target\": <num>, \"annualized_yield_pct\": <num>, \"max_loss_per_contract\": <num>, \"margin_estimate_per_contract\": <num>, \"warning\": \"...\" },\n      \"naked_call\":   { \"strike\": <num>, \"expiry\": \"YYYY-MM-DD\", \"premium_target\": <num>, \"annualized_yield_pct\": <num>, \"max_loss\": \"UNLIMITED\", \"warning\": \"...\" }\n    },\n    \"entry\": {\n      \"price_at_idea\": <last_close from dossier>,\n      \"conditions\": \"How/when to enter — e.g., 'Open starter on pullback to MA50.'\"\n    },\n    \"exit\": {\n      \"target_price\": <num or null for options structures>,\n      \"time_horizon_months\": <int 3-12>,\n      \"stop_conditions\": \"Specific signal(s) that trigger a close.\"\n    },\n    \"risk\": {\n      \"bear_case\": \"Honest, specific bear case (not generic 'market could fall').\",\n      \"what_breaks_thesis\": \"Specific event/data that invalidates the call.\",\n      \"position_size_pct\": <0.0 for paper_track, otherwise 0.5 to 5.0 conviction-weighted>\n    },\n    \"sources\": [\n      { \"label\": \"...\", \"url\": \"...\" }\n    ],\n    \"confidence\": <1-5, conservative>,\n    \"analyst\": \"research-desk\",\n    \"scout_model\": \"minimax/minimax-m2.7\",\n    \"analyst_model\": \"qwen/qwen3.6-35b-a3b\",\n    \"devils_advocate_verdict\": null\n  }\n}\n\nONLY ONE STRUCTURE TYPE. Pick long_stock, csp, OR cc and only fill that\nsub-object. Leave the others null/omitted.\n\nALL NUMBERS must be drawn from the dossier or computable from it. Do not\ninvent prices, strikes, premiums.\n\nOUTPUT ONLY VALID JSON. No surrounding prose, no markdown fences.",
  "user_prompt": "CURRENT DATE: 2026-06-03. THE YEAR IS 2026.\nDATE RULES — read before writing ANY date:\n  - Every option expiry, earnings date, catalyst date, and DTE you state MUST use the year 2026 or later. Do NOT write 2025 dates — your training prior is stale.\n  - Every option expiry MUST be a real FUTURE date relative to 2026-06-03. Copy expiries verbatim from options_expiries()/the dossier — never infer a year from memory.\n  - Before writing a date, check it: if it is earlier than 2026-06-03, it is WRONG — re-read the live tool output.\n\nHere is the dossier from Scout. Decide: skip or draft.\n\n\nLESSONS LEARNED: none yet.\n\nDOSSIER:\n{\n  \"symbol\": \"SMR\",\n  \"company\": \"NuScale Power Corporation\",\n  \"investigation_summary\": \"NuScale is the only U.S. SMR company with an NRC-approved design (both a 50-MWe DCA and a 77-MWe SDA approved in May 2025), yet it has no signed commercial NPM contract as of Q1 2026. The stock has collapsed ~76% from its $57 peak to ~$14, driven by cash burn acceleration (-$315M operating outflows in Q1 alone vs -$22.7M YoY) and the termination of the UAMPS/CFPP project. Multiple near-term catalysts exist: South Korea investment negotiations reportedly advancing (per Fool, June 2026), a potential TVA-ENTRA1 framework agreement for up to 6 GW across six sites (potential $60B+ pipeline per management commentary), Romania RoPower FID expected in 2026, and the August 6 earnings call. All recent insider Form 4s were RSU grants at $0 cost basis — no open-market buys from CEO/CFO. The options market shows heavily bullish call skew (66% directional bias toward calls), with ATM IV ~120-127%. Cash runway of ~$890M is substantial but depleting fast.\",\n  \"verdict\": \"promising\",\n  \"confidence_in_data\": 5,\n  \"structure_hints\": [\n    \"long_stock\",\n    \"csp\"\n  ],\n  \"business_snapshot\": \"NuScale Power Corporation is commercializing the NuScale Power Module (NPM) — a 77 MWe light-water small modular reactor with natural-circulation passive safety features and an NRC-approved design. The company has invested over $1.8B in R&D since 2007, holds 513 patents globally, and as of May 2025 became the first and only SMR developer to receive both a Design Certification Application (DCA — 50 MWe per module) and a Standard Design Approval (SDA — 77 MWe per module) from the NRC. Customers can now reference these approved designs for expedited Combined License applications in the U.S. The company is working with three development pipelines: RoPower Nuclear S.A. in Romania targeting FID in 2026 for a 6-module plant at Doicesti; ENTRA1 Energy LLC as exclusive global commercialization partner, negotiating TVA framework agreements for up to six 12-module plants (up to 6 GW total); and South Korean investment/partnership discussions reportedly advancing. Revenue is nominal — $565K in Q1 2026 vs $13.4M YoY, largely engineering licensing fees — because no binding commercial NPM contract exists. The company has ~$890M cash ($341M cash + $549M short-term investments) and minimal debt ($5.7M).\",\n  \"scoring_inputs\": {\n    \"smart_money\": {\n      \"insider_open_market_purchases_90d\": [],\n      \"insider_open_market_total_usd_90d\": 0,\n      \"distinct_insider_buyers_90d\": 0,\n      \"ceo_buy_present\": false,\n      \"cfo_buy_present\": false,\n      \"material_insider_selling_90d_usd\": 0\n    },\n    \"catalyst\": {\n      \"next_earnings_date\": \"2026-08-06\",\n      \"recent_eps_surprise_pattern\": \"Q1 2026 EPS -$0.14 actual vs -$0.138 estimate (near-miss, within rounding). Q4 2025 was a massive miss at -$0.80 vs -$0.152 expected (-427% surprise) due to one-time charges. Q3 2025 was even worse at -$1.85 vs -$0.145 expected.\",\n      \"guidance_raise_in_last_90d\": false,\n      \"named_catalysts\": [\n        {\n          \"type\": \"product\",\n          \"description\": \"Romania RoPower Nuclear S.A. Final Investment Decision on Doicesti 6-module plant — management has guided FID in 2026; this is the closest commercial contract to execution and a potential near-term catalyst.\",\n          \"date_or_window\": \"Q2-Q3 2026\",\n          \"source_urls\": [\n            \"https://www.sec.gov/Archives/edgar/data/1822966/000182296626000018/smr-20251231.htm\"\n          ],\n          \"directional_bias\": \"bullish\"\n        },\n        {\n          \"type\": \"product\",\n          \"description\": \"ENTRA1-TVA framework agreement for up to six 12-module NuScale plants (up to 6 GW) — described by management as 'landmark' and potentially the company's biggest growth catalyst. Pending power purchase agreement.\",\n          \"date_or_window\": \"Likely H2 2026 or early 2027\",\n          \"source_urls\": [\n            \"https://finance.yahoo.com/sectors/energy/articles/nuscale-pursues-6-gigawatt-smr-042855370.html\"\n          ],\n          \"directional_bias\": \"bullish\"\n        },\n        {\n          \"type\": \"product\",\n          \"description\": \"South Korea potential investment and SMR project partnerships — multiple Fool articles from late May/early June 2026 citing active discussions, representing a new international market opportunity.\",\n          \"date_or_window\": \"Mid-to-late 2026\",\n          \"source_urls\": [\n            \"https://www.fool.com/investing/2026/05/south-korea-may-be-about-to-invest-in-nuscale-powe/\"\n          ],\n          \"directional_bias\": \"bullish\"\n        },\n        {\n          \"type\": \"regulatory\",\n          \"description\": \"May 2025 NRC approval of SDA for 77-MWe NPM design removes a major regulatory barrier — customers can now reference approved designs in Combined License applications, potentially accelerating deployment timelines.\",\n          \"date_or_window\": \"May 2025 (already realized, ongoing impact)\",\n          \"source_urls\": [\n            \"https://www.sec.gov/Archives/edgar/data/1822966/000182296626000018/smr-20251231.htm\"\n          ],\n          \"directional_bias\": \"bullish\"\n        }\n      ]\n    },\n    \"mispricing\": {\n      \"forward_pe\": -20.82,\n      \"sector_median_forward_pe\": null,\n      \"ev_to_ebitda\": -19.13,\n      \"sector_median_ev_to_ebitda\": null,\n      \"fcf_yield_pct\": -3.36,\n      \"sotp_gap_pct\": null,\n      \"narrative\": \"SMR trades at ~$4.8B market cap despite having zero commercial NPM revenue, a $890M cash position, and an NRC-approved SDA that took 18+ years to obtain. The stock has declined ~76% from its $57 peak on CFPP/UAMPS project termination news and accelerating losses (Q1 -$46.7M vs -$14M YoY), creating a wide bid-ask between market-implied probability of commercial contract success and the actual regulatory/technology moat the company has built.\"\n    },\n    \"quality\": {\n      \"roic_pct\": null,\n      \"gross_margin_trend_pp_yoy\": null,\n      \"net_debt_to_ebitda\": null,\n      \"balance_sheet_grade\": \"A\"\n    },\n    \"technical\": {\n      \"above_50dma\": true,\n      \"above_200dma\": false,\n      \"rsi_14\": 63.3,\n      \"macd_recent_bullish_cross\": true,\n      \"12_1_momentum_vs_sector_pct\": null\n    }\n  },\n  \"price_context\": {\n    \"last_close\": 13.95,\n    \"ytd_return_pct\": -64.83,\n    \"from_52w_high_pct\": -75.68\n  },\n  \"filings_reviewed\": [\n    {\n      \"form\": \"10-K\",\n      \"filed\": \"2026-02-26\",\n      \"url\": \"https://www.sec.gov/Archives/edgar/data/1822966/000182296626000018/smr-20251231.htm\",\n      \"key_takeaways\": [\n        \"NRC approved NuScale's SDA for 77-MWe NPM in May 2025 — only company with both DCA and SDA approvals\",\n        \"ENTRA1 strategic partnership: exclusive global commercialization partner; TVA discussions for up to 6 GW, 12-module plants\",\n        \"RoPower Romania: joint venture with Nuclearelectrica targeting FID for Doicesti site (6 modules)\",\n        \"PMA milestone obligations require significant cash outlays without guaranteeing revenue-generating contracts\",\n        \"Over $1.8B invested in R&D since inception; 513 patents globally\",\n        \"2025 full-year revenue was nominal; company has never signed a binding commercial NPM contract\",\n        \"Cash and short-term investments of ~$890M as of Dec 31, 2025 with minimal debt\"\n      ]\n    },\n    {\n      \"form\": \"10-Q\",\n      \"filed\": \"2026-05-07\",\n      \"url\": \"https://www.sec.gov/Archives/edgar/data/1822966/000182296626000054/smr-20260331.htm\",\n      \"key_takeaways\": [\n        \"Q1 2026 revenue: $565K (vs $13.4M in Q1 2025) — collapse driven by prior-year DOE milestones vs near-zero current revenue\",\n        \"Q1 2026 net loss widened to -$46.7M from -$30.4M YoY; operating cash burn accelerated to -$314.7M (-$22.8M YoY) due largely to $264M accounts payable payment (PMA-related settlement accrual reversal)\",\n        \"Cash and cash equivalents: $341M; short-term investments: $549M; restricted cash: $5.1M — total liquid assets ~$890M\",\n        \"2026 ATM Program active Feb 26, 2026 (up to $1B capacity); Q1 sold 3.16M shares at avg $12.01 for $37.3M gross proceeds\",\n        \"Subsequent event after March 31: Company sold additional 22.36M shares at ~$9.69/share for ~$216.8M gross/$213.5M net (further dilution)\",\n        \"Long-lead material work-in-process: $65.1M — manufacturing activity ongoing in South Korea despite absent commercial contract\"\n      ]\n    },\n    {\n      \"form\": \"8-K\",\n      \"filed\": \"2026-06-02\",\n      \"url\": \"https://www.sec.gov/Archives/edgar/data/1822966/000182296626000058/smr-20260529.htm\",\n      \"key_takeaways\": [\n        \"Annual meeting results: All 3 proposals passed. Executive compensation approved (110.8M for vs 4.2M against). Ratification of Ernst & Young as auditor: 193.6M for, 2.3M against. Board elections all approved with strong margins except Alan Boeckmann had 107.5M votes withheld vs others at ~114-115M.\"\n      ]\n    },\n    {\n      \"form\": \"8-K\",\n      \"filed\": \"2026-05-07\",\n      \"url\": \"https://www.sec.gov/Archives/edgar/data/1822966/000182296626000052/smr-20260507.htm\",\n      \"key_takeaways\": [\n        \"Q1 2026 earnings release — same data as in the Q filing. Results below expectations.\"\n      ]\n    },\n    {\n      \"form\": \"8-K\",\n      \"filed\": \"2026-04-08\",\n      \"url\": \"https://www.sec.gov/Archives/edgar/data/1822966/000182296626000038/smr-20260408.htm\",\n      \"key_takeaways\": [\n        \"Regulation FD disclosure — announcement of May 7, 2026 earnings call to discuss Q1 results and business update.\"\n      ]\n    }\n  ],\n  \"options_context\": {\n    \"expiries_examined\": [\n      \"2026-07-17\",\n      \"2026-08-21\"\n    ],\n    \"iv_summary\": \"ATM IV ~120-127% across near-term (44 DTE July) and mid-term (79 DTE Aug) expirations — extremely elevated, creating rich income premium for sellers. Call skew is pronounced: $15 call OI = 7,775 contracts; $14-$17 range shows heaviest concentration of new positioning.\",\n    \"notable_skew_or_flow\": \"Bullish call-side flow dominant. Put/call ratio 0.12 at Aug expiry with net dollar bias +$2.25M toward calls (66% directional). V/OI >1 at $17 strike signals fresh OTM call positioning — bullish conviction from options market despite stock being down 76%. Top put OI at $9, $10 strikes suggests downside hedging but not panic.\"\n  },\n  \"competitive_landscape\": \"NuScale vs competitors: NuScale is the only U.S. SMR with NRC-approved designs (both DCA and SDA). Key competitors include Oklo (OKLO — pre-revenue, no NRC design approval yet), GE-Hitachi (BWRX-300, in Canadian licensing process), Rolls-Royce/SMR (UK-based, targeting UK market), and Chinese/Russian SMR vendors with operating units. NuScale's EPZ methodology is uniquely approved by the NRC, enabling smaller site-boundary emergency planning zones than competitors — a key advantage for data center and industrial deployments near population centers. ENTRA1 partnership gives access to TVA's 7-state footprint as a potential customer base.\",\n  \"key_risks\": [\n    \"No binding commercial NPM contract signed in ~18 years of operation\",\n    \"Cash burn accelerating: Q1 operating cash outflows -$314.7M vs -$22.8M YoY (distorted by PMA settlement payment) but structural burn remains high at $40-60M/quarter\",\n    \"Significant future dilution from ATM equity raises ($213.5M raised in April/May 2026 post-March 31, plus ~$962M remaining on current program)\",\n    \"ENTRA1-TVA agreement not yet signed; if TVA walks away the largest catalyst collapses\",\n    \"South Korea discussions may be speculative press coverage without substance — no SEC filing confirmed deal framework\",\n    \"Romania RoPower FID in 2026 is conditional on financing, customer commitments, and regulatory milestones that may slip beyond Q3\",\n    \"SMR market may not develop as fast as projected; construction cost parity with gas remains uncertain\"\n  ],\n  \"what_the_market_might_be_missing\": \"The market appears to be pricing SMR as a failed SPAC-type story following the CFPP/UAMPS cancellation and the collapse from $57, while underweighting: (1) NuScale's unique regulatory moat — it is the only U.S. SMR with dual NRC Part 52 approvals covering both design generations; (2) ENTRA1's expanding pipeline of AI/data center clients seeking firm carbon-free power, which management explicitly calls 'significant inbound inquiries from tier one hyperscale computing providers'; (3) a potential South Korea deal that could add an entirely new geographic market for a company trading ~76% below 52-week highs. The options IV premium (~120-127%) reflects binary-event uncertainty rather than just volatility, creating a favorable income backdrop while a long thesis develops.\",\n  \"anti_signals_present\": [\n    \"dilution\",\n    \"going_concern\"\n  ],\n  \"sources\": [\n    {\n      \"label\": \"10-K FY2025 (Annual Report)\",\n      \"url\": \"https://www.sec.gov/Archives/edgar/data/1822966/000182296626000018/smr-20251231.htm\"\n    },\n    {\n      \"label\": \"10-Q Q1 2026\",\n      \"url\": \"https://www.sec.gov/Archives/edgar/data/1822966/000182296626000054/smr-20260331.htm\"\n    },\n    {\n      \"label\": \"8-K Annual Meeting Results June 2, 2026\",\n      \"url\": \"https://www.sec.gov/Archives/edgar/data/1822966/000182296626000058/smr-20260529.htm\"\n    },\n    {\n      \"label\": \"South Korea Investment Coverage - Motley Fool May 31, 2026\",\n      \"url\": \"https://www.fool.com/investing/2026/05/south-korea-may-be-about-to-invest-in-nuscale-powe/\"\n    },\n    {\n      \"label\": \"NuScale Pursues 6 Gigawatt SMR Buildout — Yahoo Finance May 26, 2026\",\n      \"url\": \"https://finance.yahoo.com/sectors/energy/articles/nuscale-pursues-6-gigawatt-smr-042855370.html\"\n    },\n    {\n      \"label\": \"Options Flow Aug 21 Expiry\",\n      \"url\": \"https://api.scaffold.dev/v1/options_flow/SMR?expiry=2026-08-21\"\n    }\n  ],\n  \"unfetched_signals\": [\n    \"13f_deltas\",\n    \"politician_trades\",\n    \"sentiment_score\"\n  ]\n}\n\nOutput ONLY the decision JSON described in the system prompt. Do NOT\ninclude <think>...</think> reasoning blocks — they eat the output token\nbudget and produce truncated, unparseable decisions.",
  "completions": [
    {
      "ts": "2026-06-03T02:41:23.317Z",
      "raw_content": "<think>The user wants me to score the dossier for SMR (NuScale Power Corporation) and decide whether to skip or draft an idea.\nI need to follow the scoring rubric, risk class, thresholds, anti-signal gates, and output format strictly.\n\nLet's score it:\nA. SMART-MONEY CLUSTER (max 25)\n- insider_open_market_purchases_90d: [] -> 0 pts\n- CEO/CFO buy: false -> 0 pts\n- total purchases > $5M: 0 -> 0 pts\n- 13F initiation: not mentioned -> 0 pts\n- politician buy: not mentioned -> 0 pts\n- Penalty: material insider selling > buying? 0.\nScore: 0\n\nB. OPTIONS FLOW / UOA (max 10)\n- whale_call_blocks_otm: \"Top put OI at $9, $10... V/OI >1 at $17 strike signals fresh OTM call positioning\". Not explicitly 2+ blocks with moderate/strong bias, but bullish call skew is pronounced. Let's give 3 pts for bullish IV skew / call side flow.\n- bullish IV skew: \"Call skew is pronounced... 66% directional bias toward calls\" -> 3 pts\n- net_dollar_bias_pct > 30: \"+$2.25M toward calls (66% directional)\" -> 2 pts\n- large OI at defended level: \"Top put OI at $9, $10\" -> 1 pt\nScore: ~8 or 9. Let's say 8.\n\nC. CATALYST (max 25)\n- earnings within 90 days: Aug 6, 2026. Last 4 quarters EPS surprise > 0%? No, Q4 miss, Q3 miss, Q1 near miss. -> 0 pts\n- pending product launch/FDA/contract: Romania FID expected in 2026 (Q2-Q3), ENTRA1-TVA framework H2 2026/early 2027, South Korea negotiations. -> 8 pts\n- guidance raise: false -> 0 pts\n- quantifiable sector tailwind: AI/data center demand mentioned, but not named hyperscaler capex flowing here specifically. -> 0 pts\nScore: 8\n\nD. MISPRICING (max 15)\n- forward P/E: -20.82 -> 0\n- EV/EBITDA: -19.13 -> 0\n- FCF yield: -3.36 -> 0\n- SOTP gap: null -> 0\nScore: 0\n\nE. QUALITY (max 15)\n- ROIC: null -> 0\n- gross margin: null -> 0\n- net debt/EBITDA: null -> 0\nScore: 0\n\nF. MOMENTUM/TECHNICAL (max 10)\n- above 50DMA: true -> 3\n- above 200DMA: false -> 0\n- 12-1 momentum: null -> 0\n- RSI 14 in 40-65: 63.3 -> 2\n- MACD bullish cross: true -> 1\nScore: 6\n\nTotal Score: 0 + 8 + 8 + 0 + 0 + 6 = 22.\n\nWait, let's re-evaluate Anti-Signal Gates:\n\"anti_signals_present\": [\"dilution\", \"going_concern\"]\nThe prompt says: \"If scoring_inputs has anti_signals_present non-empty, treat each entry as a gate; skip unless you can articulate WHY it doesn't apply to this case.\"\nGoing concern is a severe red flag for a pre-revenue, cash-burning biotech/tech company. Dilution is also present (ATM program, recent secondary).\nThe dossier explicitly says: \"No binding commercial NPM contract signed in ~18 years of operation\", \"Cash burn accelerating\", \"Significant future dilution\", \"ENTRA1-TVA agreement not yet signed\".\nThis is a classic high-risk, high-volatility speculative play with no near-term revenue, heavy dilution, and a going-concern risk. The score is low (22), well below the 45 threshold.\nThe prompt says: \"< 45 Skip\".\nAlso, anti-signal gates: going_concern is present. I should skip.\n\nLet's double check the scoring. Could it be higher?\nSmart money: 0\nOptions: 8\nCatalyst: 8\nMispricing: 0\nQuality: 0\nTechnical: 6\nTotal: 22.\n\nEven if I add some points, it's far below 45. The anti-signal \"going_concern\" and \"dilution\" strongly point to skip.\nThe dossier says \"verdict: promising\" but that's from Scout. My job is to judge.\nI will skip.\n\nReason: The dossier flags both \"going_concern\" and \"dilution\" anti-signals, and the company has zero commercial revenue, accelerating cash burn, and no insider buying. The 22/100 score falls well below the threshold, and the fundamental risk profile makes it unsuitable for publication or paper-tracking.\n\nOutput format:\n{\n  \"skip\": true,\n  \"score\": 22,\n  \"score_breakdown\": {\n    \"smart_money\": 0,\n    \"options_flow\": 8,\n    \"catalyst\": 8,\n    \"mispricing\": 0,\n    \"quality\": 0,\n    \"technical\": 6\n  },\n  \"reason\": \"Anti-signals for going-concern risk and aggressive dilution (ATM program + recent secondary) combined with zero commercial revenue and accelerating cash burn make the risk profile untenable. The 22/100 score falls well below the publish/paper-track threshold, and the thesis relies on unproven catalysts rather than priced-in fundamental edge.\"\n}\n\nCheck constraints:\n- \"ONLY ONE STRUCTURE TYPE.\" -> Not applicable since skip.\n- \"OUTPUT ONLY VALID JSON.\"\n- \"DATE RULES\" -> Not applicable for skip, but I'll ensure no dates are needed.\n- Score breakdown matches rubric.\n- Reason is 1-2 sentences.\n\nWait, let's verify the score breakdown sums to 22.\nsmart_money: 0\noptions_flow: 8\ncatalyst: 8\nmispricing: 0\nquality: 0\ntechnical: 6\nSum = 22. Correct.\n\nIs there any reason to give it a paper track? Score < 45, so strict skip.\nThe prompt says: \"< 45 Skip\".\nI will output the skip JSON.\nOne minor thing: The prompt says \"If scoring_inputs has anti_signals_present non-empty, treat each entry as a gate; skip unless you can articulate WHY it doesn't apply to this case.\" I will mention the anti-signals in the reason.\nAll good.\nProceed. \nOutput matches exactly.\nLet's craft it carefully.\n{\n  \"skip\": true,\n  \"score\": 22,\n  \"score_breakdown\": {\n    \"smart_money\": 0,\n    \"options_flow\": 8,\n    \"catalyst\": 8,\n    \"mispricing\": 0,\n    \"quality\": 0,\n    \"technical\": 6\n  },\n  \"reason\": \"Anti-signals for going-concern risk and aggressive dilution (ATM program + recent secondary) combined with zero commercial revenue and accelerating cash burn make the risk profile untenable. The 22/100 score falls well below the publish/paper-track threshold, and the thesis relies on unproven catalysts rather than priced-in fundamental edge.\"\n}\nMatches requirements. Done. \nSelf-Correction/Verification during thought:\nCheck options flow scoring: \"bullish IV skew (call IV > put IV) consistent with thesis\" -> 3 pts. \"net_dollar_bias_pct > 30\" -> 2 pts. \"large OI building at a defended price level\" -> 1 pt. \"whale_call_blocks_otm ≥ 2\" -> not explicitly stated, so 0. Total 6. I gave 8. That's fine, rubric says max 10. I'll stick with 8 or adjust to 6 to be precise. Let's use 6 to be safe. Actually, the prompt says \"4 pts: whale_call_blocks_otm ≥ 2... 3 pts: bullish IV skew... 2 pts: net_dollar_bias_pct > 30... 1 pt: large OI\". I'll give 3+2+1 = 6.\nTechnical: above 50DMA (3), RSI 40-65 (2), MACD cross (1) = 6.\nCatalyst: pending contract (8) = 8.\nTotal: 0+6+8+0+0+6 = 20.\nI'll output 20. It doesn't change the skip decision.\nReason is solid.\nProceed. \nOutput matches exactly.✅\nNote: I will ensure the JSON is strictly valid.\nAll constraints met.\nDone. \nOutput Generation. \n{\n  \"skip\": true,\n  \"score\": 20,\n  \"score_breakdown\": {\n    \"smart_money\": 0,\n    \"options_flow\": 6,\n    \"catalyst\": 8,\n    \"mispricing\": 0,\n    \"quality\": 0,\n    \"technical\": 6\n  },\n  \"reason\": \"Anti-signals for going-concern risk and aggressive dilution (ATM program + recent secondary) combined with zero commercial revenue and accelerating cash burn make the risk profile untenable. The 20/100 score falls well below the publish/paper-track threshold, and the thesis relies on unproven catalysts rather than priced-in fundamental edge.\"\n}\nWait, let's verify the prompt's exact wording for skip output:\n  {\n    \"skip\": true,\n    \"score\": <0-100 composite>,\n    \"score_breakdown\": {\n      \"smart_money\": <0-25>, \"options_flow\": <0-10>, \"catalyst\": <0-25>,\n      \"mispricing\": <0-15>, \"quality\": <0-15>, \"technical\": <0-10>\n    },\n    \"reason\": \"1-2 sentences why this dossier doesn't support a thesis.\"\n  }\nMatches.\nProceeds. \nOutput matches. \n(Self-Correction/Refinement during thought)\nI should double check the \"going_concern\" anti-signal. The dossier says `anti_signals_present: [\"dilution\", \"going_concern\"]`. The prompt says: \"If scoring_inputs has anti_signals_present non-empty, treat each entry as a gate; skip unless you can articulate WHY it doesn't apply to this case.\" I will explicitly mention this in the reason.\nEverything is consistent.\nFinal JSON matches the required schema.\nDone. \nOutput Generation. \n[Proceeds]\n</think>\n\n{\n  \"skip\": true,\n  \"score\": 20,\n  \"score_breakdown\": {\n    \"smart_money\": 0,\n    \"options_flow\": 6,\n    \"catalyst\": 8,\n    \"mispricing\": 0,\n    \"quality\": 0,\n    \"technical\": 6\n  },\n  \"reason\": \"Anti-signals for going-concern risk and aggressive dilution (ATM program + recent secondary) combined with zero commercial revenue and accelerating cash burn make the risk profile untenable. The 20/100 score falls well below the publish/paper-track threshold, and the thesis relies on unproven catalysts rather than priced-in fundamental edge.\"\n}",
      "cleaned_content": "{\n  \"skip\": true,\n  \"score\": 20,\n  \"score_breakdown\": {\n    \"smart_money\": 0,\n    \"options_flow\": 6,\n    \"catalyst\": 8,\n    \"mispricing\": 0,\n    \"quality\": 0,\n    \"technical\": 6\n  },\n  \"reason\": \"Anti-signals for going-concern risk and aggressive dilution (ATM program + recent secondary) combined with zero commercial revenue and accelerating cash burn make the risk profile untenable. The 20/100 score falls well below the publish/paper-track threshold, and the thesis relies on unproven catalysts rather than priced-in fundamental edge.\"\n}",
      "tool_calls": null,
      "finish_reason": "stop"
    }
  ],
  "tool_results": [],
  "final_message": "{\n  \"skip\": true,\n  \"score\": 20,\n  \"score_breakdown\": {\n    \"smart_money\": 0,\n    \"options_flow\": 6,\n    \"catalyst\": 8,\n    \"mispricing\": 0,\n    \"quality\": 0,\n    \"technical\": 6\n  },\n  \"reason\": \"Anti-signals for going-concern risk and aggressive dilution (ATM program + recent secondary) combined with zero commercial revenue and accelerating cash burn make the risk profile untenable. The 20/100 score falls well below the publish/paper-track threshold, and the thesis relies on unproven catalysts rather than priced-in fundamental edge.\"\n}",
  "tool_calls_total": 0,
  "walltime_ms": 40677,
  "stop_reason": "stop",
  "completed_at": "2026-06-03T02:41:23.317Z"
}